Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.00
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

3 Dec 2010 07:00

RNS Number : 2978X
Medavinci PLC
03 December 2010
 



 

 

 

MedaVinci plc ( "MedaVinci" or the "Company")

Placing to raise £1.5 million

 

Highlights

The Board of MedaVinci is pleased to announce that the Company has raised £1.5 million, before expenses, through the issue of 375,000,000 new ordinary shares of 0.1p each ("Placing Shares") at a price of 0.4p per share (the "Placing").

 

The Placing is conditional on the Placing Shares being admitted to AIM ("Admission"). Application has been made for the Placing Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the Placing Shares will commence on 8 December 2010. Upon Admission the Placing Shares will rank pari passu in all respects with the existing ordinary shares in issue.

 

Background

In September 2010, the Company acquired 49 per cent. of the issued share capital of Orogen Gold Limited ("Orogen Gold") for a total consideration of £370,000 in cash and ordinary shares, with an option to acquire the remaining 51 per cent. within 12 months. Orogen Gold was formed to hold investments in companies involved in mineral exploration and related activities and is seeking to explore and develop gold deposits in Europe.

 

The Initial focus is on the Deli Jovan Gold Project, a 69 sq km permit-area in eastern Serbia covering two historical shallow underground gold mines (the Rusman and Ginduša Mines), that were last in production pre World War II, and over which Orogen Gold has an Earn-in Agreement. Under the Earn-in Agreement Orogen Gold has the right to an initial interest of 55 per cent. in the Deli Jovan Gold Project if it spends a minimum of C$1.5 million (£945,000) on exploration by 20 June 2012 and a further interest of 20 per cent. upon an additional spend of C$2.0 million (£1.26 million) by 20 December 2013, giving Orogen Gold an aggregate interest in 75 per cent. of the Deli Jovan Gold Project.

 

Strategy

The initial objective of a detailed and phased Exploration Programme is to demonstrate an initial 100,000 oz inferred gold resource at the Rusman and Ginduša Mines which is envisaged to be sufficient to under pin two to three years of mine production.

 

The initial stage Phase I Exploration Programme, which will comprise surface trenching, re opening and re sampling three underground levels at the Rusman and Ginduša Mines and may also include some diamond drilling. This phase will also include reconnaissance exploration along the eight kilometre trend which includes gold prospects at Cuka Perina and Seliste. Phase 1 works will cost approximately £600,000 (C$950,000) and is expected to take 12 months. The second stage Phase exploration programme will involve driving new underground development with detailed channel sampling intended to confirm lateral continuity of mineralisation. More systematic diamond drilling from the surface is intended to confirm further lateral and depth continuity of the mineralised structures, is expected to cost approximately £1.1 million (C£1.74 million) and to take a further 9 months.

 

Contingent on success in Phase I, a Phase II Exploration Programme will commence which will include diamond drilling and new underground development and sampling to determine whether there are sufficient gold reserves to support an initial two to three years of production. Once in production the intention is to fund the blocking out of new resources from cash-flow and this will involve extending underground headings to determine grade and drilling to establish continuity in the lodes. It is estimated that Phase II will cost £1.25 million (C$1.97 million) and will take 12 months

 

MedaVinci's medium term strategy is to develop Deli Jovan as a revenue generating project which will provide a base to expand into other gold project exploration development opportunities in Europe and further east.

 

Placing and Use of proceeds

Under the terms of the Placing Agreement, Xcap Securities plc ("Xcap") has used reasonable endeavours to procure subscribers for the Placing Shares and will receive a commission on the gross funds that they have raised. In addition, Xcap has been granted warrants over 5 million new ordinary shares exercisable within 5 years of the date of Admission, at an exercise price of 0.4p per share.

 

The net proceeds of the Placing will be used to fund both stages of the Company's Phase I Exploration Programme at the Rusman and Ginduša Mines.

 

Related Party Transaction

The Directors are participating in the Placing as follows:

 

Mr Michael Hough, director, subscribed for 25,000,000 ordinary shares in the Company pursuant to the Placing. Following this subscription, Michael Hough is interested in 107,500,000 ordinary shares in the Company (representing approximately 7.94 per cent. of the issued share capital).

 

Mr Glyn Hirsch, director, subscribed for 7,500,000 new ordinary shares in the Placing. Following this subscription Glyn Hirsch is interested in 90,000,000 ordinary shares (representing approximately 6.65 per cent. of the issued share capital).

 

Mr Adam Reynolds, chairman, subscribed for 12,500,000 ordinary shares pursuant to the Placing. This subscription was effected through his shareholding in Diablo Consulting Limited, which subscribed for 25,000,000 ordinary shares, in which he holds 50 per cent. of the issued share capital. Following this subscription, the total shareholding of Adam Reynolds in the Company amounts to 55,500,000 ordinary shares (representing approximately 4.10 per cent. of the issued share capital).

Mr Paul Foulger, finance director, subscribed for 12,500,000 ordinary shares pursuant to the Placing. This subscription was effected through his shareholding in Diablo Consulting Limited, which subscribed for 25,000,000 shares, in which he holds 50 per cent. of the issued share capital. Following this subscription, the total shareholding of Paul Foulger in the Company amounts to 55,500,000 ordinary shares (representing approximately 4.10 per cent. of the issued share capital).

 

The Directors' participation in the Placing is a related party transaction under the AIM Rules. The independent director of the Company being Michael Nolan, who has consulted the Company's nominated adviser, Zeus Capital, considers the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Adam Reynolds, Chairman of MedaVinci plc, commented: "This is a significant step forward for MedaVinci and the net proceeds of the Placing will be used to fund the Phase I Exploration Programme at the Deli Jovan Gold Project".

 

Contact Details:

 

MedaVinci plc

Adam Reynolds Tel: +44 (0) 207 245 1100

Paul Foulger

 

Zeus Capital Limited Tel +44 (0)161 831 1512

Ross Andrews

Tom Rowley

 

Xcap Securities plc Tel: +44 (0)207 101 7070

Tim Burge

Karen Kelly

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUGGAPPUPUGQP
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.